CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: IMA-PRESS LLC 2018-05-01
Seri Bilgileri:Научно-практическая ревматология
Konular:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Online Erişim:https://rsp.mediar-press.net/rsp/article/view/2524
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller